The DSM-5 Self-Rated Level 1 Cross-Cutting Symptom Measure identifies high levels of coexistent psychiatric symptomatology in patients referred for insomnia treatment
Hailey Meaklim,1,2 John Swieca,1 Moira Junge,1 Irena Laska,1 Danielle Kelly,1,3 Rosemarie Joyce,1,3 David Cunnington1 1Melbourne Sleep Disorders Centre, East Melbourne, VIC, Australia; 2Discipline of Psychology, RMIT University, Bundoora, VIC, Australia; 3Sleep Disorders Unit, St Vincent’s...
Guardado en:
Autores principales: | Meaklim H, Swieca J, Junge M, Laska I, Kelly D, Joyce R, Cunnington D |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/208e029c48c44738b2296009fcbc4ae0 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Acupuncture: A Promising Approach for Comorbid Depression and Insomnia in Perimenopause
por: Zhao FY, et al.
Publicado: (2021) -
Impact of Acupuncture on Sleep and Comorbid Symptoms for Chronic Insomnia: A Randomized Clinical Trial
por: Wang C, et al.
Publicado: (2021) -
Evaluation of effectiveness and safety of a herbal compound in primary insomnia symptoms and sleep disturbances not related to medical or psychiatric causes
por: Palmieri G, et al.
Publicado: (2017) -
Impact Of Phenotypic Heterogeneity Of Insomnia On The Patients’ Response To Cognitive-Behavioral Therapy For Insomnia: Current Perspectives
por: Galbiati A, et al.
Publicado: (2019) -
Gut Microbiota Changes and Their Relationship with Inflammation in Patients with Acute and Chronic Insomnia
por: Li Y, et al.
Publicado: (2020)